Lexicon Announces Positive Phase 2 Results Of LX1031 In Non-Constipating Irritable Bowel Syndrome
Links shared publicly online about this topic.
- 1,606total visits
Lexicon Announces Positive Phase 2 Results Of LX1031 In Non-Constipating Irritable Bowel Syndrome
View full resource at medicalnewstoday.com
Tags: IBS, Disease and Condition, Drug, Pharma
Most Recently Shared on November 13, 2009 at 1:10 pm By:
Lexicon Announces Positive Phase 2 Results Of LX1031 In Non-Constipating Irritable Bowel Syndrome: Lexicon Phar.. http://bit.ly/1V3jJU
Gastroenterology journal publishes results of Lexicon LX1031 Phase 2 trial in IBS
news-medical.net — “Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that results from the Phase 2 clinical trial of LX1031 in patients with non-constipating irritable bowel syndrome (IBS) were published earlier this week in the August 2011 edition of the journal Gastroenterology.” View full resource at news-medical.net
Most Recently Shared on August 11, 2011 at 11:43 am By:
Irritable Bowel Syndrome OW Health
Gastroenterology journal publishes results of Lexicon LX1031 Phase 2 trial in IBS: Lexicon Pharmaceuticals, Inc.... http://bit.ly/qoXBv4
Advertisement
